Cited by 2,435HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV Research and Treatment

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Open access

Abdool Karim, Quarraisha, Abdool Karim, Salim S., Frohlich, Janet A., Grobler, Anneke C., Baxter, Cheryl, Mansoor, Leila E., Kharsany, Ayesha B. M., Sibeko, Sengeziwe, Mlisana, Koleka P., Omar, Zaheen, Gengiah, Tanuja N., Maarschalk, Silvia, Arulappan, Natasha, Mlotshwa, Mukelisiwe, Morris, Lynn, Taylor, Douglas, on behalf of the CAPRISA 004 Trial Group·2010·Science

DOI 10.1126/science.1193748PMC PMC3001187

Open this paper in CoChat — free account

Abstract

The Centre for the AIDS Program of Research in South Africa (CAPRISA) 004 trial assessed the effectiveness and safety of a 1% vaginal gel formulation of tenofovir, a nucleotide reverse transcriptase inhibitor, for the prevention of HIV acquisition in women. A double-blind, randomized controlled trial was conducted comparing tenofovir gel (n = 445 women) with placebo gel (n = 444 women) in sexually active, HIV-uninfected 18- to 40-year-old women in urban and rural KwaZulu-Natal, South Africa. HIV serostatus, safety, sexual behavior, and gel and condom use were assessed at monthly follow-up visits for 30 months. HIV incidence in the tenofovir gel arm was 5.6 per 100 women-years (person time of study observation) (38 out of 680.6 women-years) compared with 9.1 per 100 women-years (60 out of 660.7 women-years) in the placebo gel arm (incidence rate ratio = 0.61; P = 0.017). In high adherers (gel adherence > 80%), HIV incidence was 54% lower (P = 0.025) in the tenofovir gel arm. In intermediate adherers (gel adherence 50 to 80%) and low adherers (gel adherence < 50%), the HIV incidence reduction was 38 and 28%, respectively. Tenofovir gel reduced HIV acquisition by an estimated 39% overall, and by 54% in women with high gel adherence. No increase in the overall adverse event rates was observed. There were no changes in viral load and no tenofovir resistance in HIV seroconverters. Tenofovir gel could potentially fill an important HIV prevention gap, especially for women unable to successfully negotiate mutual monogamy or condom use.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/science.1193748

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks‐Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M. S., Adams, E. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,036
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., & Puren, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020298 · Cited by 2,451
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., Krieger, J. N., Williams, C. F., Campbell, R. T., & Ndinya-Achola, J. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60312-2 · Cited by 2,292
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chaudhary, M. A., Chen, M. Z., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60313-4 · Cited by 2,226
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial
Grosskurth, H., Todd, J., Mwijarubi, E., Mayaud, P., Nicoll, A., ka-Gina, G., Newell, J., Grosskurth, H., Todd, J., Mayaud, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91380-7 · Cited by 1,387
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial
Damme, L. V., Gita Ramjee, H., Alary, M., Vuylsteke, B., Chandeying, V., Rees, H., Sirivongrangson, P., Mukenge-Tshibaka, L., Ettiègne-Traoré, V., Uaheowitchai, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11079-8 · Cited by 796
Prevention of SIV Infection in Macaques by ( R )-9-(2-Phosphonylmethoxypropyl)adenine
Tsai, C., Follis, K. E., Sabó, A., Beck, T. W., Grant, R., Bischofberger, N., Benveniste, R. Ė., & Black, R. J. (1995) · Science · doi:10.1126/science.270.5239.1197 · Cited by 563
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response
Karim, S. S. A., Churchyard, G., Karim, Q. A., & Lawn, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60916-8 · Cited by 544

Show all 33 references

Research works printed but not linked: 1

R. S. Brown D. Goodwin S. Zhang E. Fagan paper presented at the 13th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD) Washington DC 20 to 24 March 2009.

Sorted by citations

Items 501–600 of 1,005

Triple Combination of Carbosilane Dendrimers, Tenofovir and Maraviroc as Potential Microbicide to Prevent HIV-1 Sexual Transmission
Sepúlveda‐Crespo, D., Sánchez-Rodríguez, J., Serramía, M. J., Gómez, R., de la Mata, F. J., Jiménez, J. L., & Muñoz‐Fernández, M. Á. (2015) · Nanomedicine · doi:10.2217/nnm.14.79 · Cited by 49
Retrocyclins and their activity against HIV-1
Penberthy, W. T., Chari, S., Cole, A. L., & Cole, A. M. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0715-5 · Cited by 52
Testing for acute HIV infection
Owen, S. M. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283506613 · Cited by 51
Anal Sex, Vaginal Practices, and HIV Incidence in Female Sex Workers in Urban Kenya: Implications for the Development of Intravaginal HIV Prevention Methods
Priddy, F. H., Wakasiaka, S., Hoang, T. D. M., Smith, D. J., Farah, B., del Rı́o, C., & Ndinya‐Achola, J. O. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0362 · Cited by 49
HIV prevention research: taking stock and the way forward
Hayes, R., Kapiga, S., PADIAN, N. S., McCormack, S., & Wasserheit, J. N. (2010) · AIDS · doi:10.1097/01.aids.0000390710.04255.2b · Cited by 49
Nanomedicine applications towards the cure of HIV
Lisziewicz, J., & Tőke, E. R. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.012 · Cited by 51
Assessment of topical microbicides to prevent HIV-1 transmission: Concepts, testing, lessons learned
Friend, D. R., & Kiser, P. F. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.06.021 · Cited by 48
Human Immunodeficiency Virus Infection : from Biological Observations to Mechanistic Mathematical Modelling
Bocharov, G. A., Черешнев, В. А., Gainova, I., Bazhan, S. I., Bachmetyev, B. A., Argilaguet, J. M., Martínez, J. P., & Meyerhans, A. (2012) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/20127507 · Cited by 48
HIV Pre-Exposure Prophylaxis Interest among Female Sex Workers in Guangxi, China
Ye, L., Wei, S., Zou, Y., Yang, X., Abdullah, A. S. M., Zhong, X., Ruan, Y., Lin, X., Li, M., Wu, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086200 · Cited by 48
Efficacy, Stability, and Biosafety of Sifuvirtide Gel as a Microbicide Candidate against HIV-1
Li, L., Ben, Y., Yuan, S., Jiang, S., Xu, J., & Zhang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037381 · Cited by 48
The risk of HIV transmission within HIV-1 sero-discordant couples appears to vary across sub-Saharan Africa
Chemaitelly, H. S., Awad, S. F., & Abu-Raddad, L. J. (2013) · Epidemics · doi:10.1016/j.epidem.2013.11.001 · Cited by 48
Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers
Doncel, G. F., & Clark, M. R. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.09.018 · Cited by 48
Dendrimers as topical microbicides with activity against HIV
Jiménez, J. L., Pion, M., de la Mata, F. J., Gómez, R., Muñóz, E., Leal, M., & Muñoz‐Fernández, M. Á. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20396g · Cited by 48
HIV sexual transmission and microbicides
Ariën, K. K., Jespers, V., & Vanham, G. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.684 · Cited by 48
Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs)
Fu, Y., Jaarsma, A. H., & Kuipers, O. P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03759-0 · Cited by 48
The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women
Velloza, J., & Heffron, R. A. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0362-z · Cited by 47
Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review
Tan, D. H. S., Senn, H., Sharma, M., & Wilton, J. (2015) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s50025 · Cited by 51
Enema ion compositions for enhancing colorectal drug delivery
Maisel, K., Chattopadhyay, S., Moench, T. R., Hendrix, C. W., Cone, R. A., Ensign, L. M., & Hanes, J. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.040 · Cited by 49
Intimate Partner Violence and Condom and Diaphragm Nonadherence Among Women in an HIV Prevention Trial in Southern Africa
Kacanek, D., Bostrom, A., Montgomery, E., Ramjee, G., de Bruyn, G., Blanchard, K., Rock, A., Mtetwa, S., & van der Straten, A. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182a6b0be · Cited by 51
Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France
Lorente, N., Fugon, L., Carrieri, P., Andreo, C., Gall, J.-M. L., Cook, E., Aboulker, J.-P., Capitant, C., Molina, J., & Spire, B. (2011) · AIDS Care · doi:10.1080/09540121.2011.626394 · Cited by 47
The development of rectal microbicides for HIV prevention
McGowan, I. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.860132 · Cited by 47
“Tell Juliana”: Acceptability of the Candidate Microbicide VivaGel® and Two Placebo Gels Among Ethnically Diverse, Sexually Active Young Women Participating in a Phase 1 Microbicide Study
Carballo‐Diéguez, A., Giguere, R., Dolezal, C. L., Chen, B. A., Kahn, J. A., Zimet, G. D., Mabragaña, M., Leu, C., & McGowan, I. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-0028-6 · Cited by 47
Disclosure of Microbicide Gel Use to Sexual Partners: Influence on Adherence in the CAPRISA 004 Trial
Mngadi, K. T., Maarschalk, S., Grobler, A. C., Mansoor, L. E., Frohlich, J., Madlala, B. T., Ngcobo, N., Karim, S. S. A., & Karim, Q. A. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0696-0 · Cited by 47
Self-citation
HIV treatment as prevention: The key to an AIDS-free generation
Hull, M., & Montaner, J. S. G. (2013) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2013.09.043 · Cited by 50
The Griffithsin Dimer Is Required for High-Potency Inhibition of HIV-1: Evidence for Manipulation of the Structure of gp120 as Part of the Griffithsin Dimer Mechanism
Xue, J., Hoorelbeke, B., Kagiampakis, I., Demeler, B., Balzarini, J. M., & LiWang, P. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00332-13 · Cited by 47
Making prevention public: The co-production of gender and technology in HIV prevention research
Montgomery, C. M. (2012) · Social Studies of Science · doi:10.1177/0306312712457707 · Cited by 47
Safety and Pharmacokinetics of Intravaginal Rings Delivering Tenofovir in Pig-Tailed Macaques
Moss, J. A., Malone, A. M. D., Smith, T. J., Butkyavichene, I., Cortez, C., Gilman, J., Kennedy, S., Kopin, E. G., Nguyen, C., Sinha, P., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-12 · Cited by 47
Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin family
Férir, G., Huskens, D., Noppen, S., Koharudin, L. M. I., Gronenborn, A. M., & Schols, D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku220 · Cited by 47
Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men
Okano, J. T., Robbins, D., Palk, L., Gerstoft, J., Obel, N., & Blower, S. M. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30022-6 · Cited by 47
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women
Carballo‐Diéguez, A., Balán, I. C., Brown, W., Giguere, R., Dolezal, C. L., Leu, C., Marzinke, M. A., Hendrix, C. W., Piper, J. M., Richardson, B. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181607 · Cited by 47
Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV
Notario-Pérez, F., Cazorla-Luna, R., Martín-Illana, A., Ruíz, R., Tamayo, A., Rubio, J., & Veiga, M.-D. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.10.001 · Cited by 47
Reported oral and anal sex among adolescents and adults reporting heterosexual sex in sub-Saharan Africa: a systematic review
Morhason-Bello, I. O., Kabakama, S., Baisley, K. J., Francis, S. C., & Watson‐Jones, D. (2019) · Reproductive Health · doi:10.1186/s12978-019-0722-9 · Cited by 47
Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections
Friend, D. R. (2011) · Drug Delivery and Translational Research · doi:10.1007/s13346-011-0024-4 · Cited by 47
Úlceras genitales por virus herpes simplex
Parra-Sánchez, M. (2018) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2018.10.020 · Cited by 46
Cervico‐Vaginal Tissue Ex Vivo as a Model to Study Early Events in HIV‐1 Infection
Merbah, M., Introini, A., Fitzgerald, W., Grivel, J., Lisco, A., Vanpouille, C., & Margolis, L. B. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00967.x · Cited by 46
Protein-Free Efavirenz Concentrations in Cerebrospinal Fluid and Blood Plasma Are Equivalent: Applying the Law of Mass Action To Predict Protein-Free Drug Concentration
Avery, L. B., Sacktor, N. C., McArthur, J. C., & Hendrix, C. W. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02329-12 · Cited by 46
Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
Ravel, J., Gajer, P., Fu, L., Mauck, C. K., Koenig, S. S. K., Sakamoto, J. M., Motsinger‐Reif, A. A., Doncel, G. F., & Zeichner, S. L. (2012) · mBio · doi:10.1128/mbio.00370-12 · Cited by 46
Hyaluronidase-Sensitive Nanoparticle Templates for Triggered Release of HIV/AIDS Microbicide In Vitro
Agrahari, V., Zhang, C., Zhang, T., Li, W., Gounev, T. K., Oyler, N. A., & Youan, B.-B. C. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9546-7 · Cited by 46
Finding a cure for HIV: will it ever be achievable?
Lewin, S. R., Evans, V. A., Elliott, J. H., Spire, B., & Chomont, N. (2011) · Journal of the International AIDS Society · doi:10.1186/1758-2652-14-4 · Cited by 46
Pharmacokinetics of a Multipurpose Pod-Intravaginal Ring Simultaneously Delivering Five Drugs in an Ovine Model
Moss, J. A., Malone, A. M. D., Smith, T. J., Kennedy, S., Nguyen, C., Vincent, K. L., Motamedi, M., & Baum, M. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00547-13 · Cited by 46
Stimuli-Sensitive Thiolated Hyaluronic Acid Based Nanofibers: Synthesis, Preclinical Safety And in vitro Anti-HIV Activity
Agrahari, V., Meng, J., Ezoulin, M. J. M., Youm, I., Dim, D. C., Molteni, A., Hung, W., Christenson, L. K., & Youan, B.-B. C. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0103 · Cited by 46
Topical Microbicides in HIV Prevention: State of the Promise
Baeten, J. M., Hendrix, C. W., & Hillier, S. L. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-090518-093731 · Cited by 46
A Review of Pre-Exposure Prophylaxis Adherence among Female Sex Workers
Ghayda, R. A., Hong, S. H., Yang, J. W., Jeong, G. H., Lee, K. H., Kronbichler, A., Solmi, M., Stubbs, B., Koyanagi, A., Jacob, L., et al. (2020) · Yonsei Medical Journal · doi:10.3349/ymj.2020.61.5.349 · Cited by 46
The design and evaluation of HIV-1 vaccines
Saunders, K. O., Rudicell, R. S., & Nabel, G. J. (2012) · AIDS · doi:10.1097/qad.0b013e32835474d2 · Cited by 47
Fertility-related research needs among women at the margins
Schwartz, S., & Baral, S. (2015) · Reproductive Health Matters · doi:10.1016/j.rhm.2015.06.006 · Cited by 45
Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis
Obiero, J. A., Mwethera, P. G., Hussey, G. D., & Wiysonge, C. S. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-289 · Cited by 45
Current thinking on genital herpes
Hofstetter, A. M., Rosenthal, S. L., & Stanberry, L. R. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000029 · Cited by 45
Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG
Hartjen, P., Frerk, S., Hauber, I., Matzat, V., Thomssen, A., Holstermann, B., Hohenberg, H., Schulze, W., Wiesch, J. S. Z., & van Lunzen, J. (2012) · AIDS Research and Therapy · doi:10.1186/1742-6405-9-2 · Cited by 45
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides
Adams, J. L., & Kashuba, A. D. M. (2012) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2012.01.004 · Cited by 45
Portfolios of Biomedical HIV Interventions in South Africa: A Cost-Effectiveness Analysis
Long, E. F., & Stavert, R. R. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2417-1 · Cited by 45
Evaluating cognitive impairment in the clinical setting: practical screening and assessment tools.
Valcour, V. (2011) · Europe PMC (PubMed Central) · Cited by 45
Postexposure Protection of Macaques from Vaginal SHIV Infection by Topical Integrase Inhibitors
Dobard, C., Sharma, S., Parikh, U. M., West, R., Taylor, A., Martin, A. M., Pau, C., Hanson, D. L., Lipscomb, J. T., Smith, J. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007701 · Cited by 44
Animal models of antiretroviral prophylaxis for HIV prevention
Garcia-Lerma, J. G., & Heneine, W. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328358e484 · Cited by 44
Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis
Plosker, G. L. (2013) · Drugs · doi:10.1007/s40265-013-0024-4 · Cited by 45
Sexual Healthcare Preferences among Gay and Bisexual Men: A Qualitative Study in San Francisco, California
Koester, K. A., Collins, S. P., Fuller, S. M., Galindo, G. R., Gibson, S., & Steward, W. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071546 · Cited by 49
Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir
Murphy, D. J., Desjardins, D., Dereuddre‐Bosquet, N., Brochard, P., Perrot, L., Pruvost, A., Grand, R. L., Lagatie, O., Vanhooren, L., Feyaerts, M., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku160 · Cited by 44
Can Combination Prevention Strategies Reduce HIV Transmission in Generalized Epidemic Settings in Africa? The HPTN 071 (PopART) Study Plan in South Africa and Zambia
Vermund, S. H., Fidler, S. J., Ayles, H., Beyers, N., & Hayes, R. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318299c3f4 · Cited by 44
Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study
Nichols, B. E., Boucher, C. A., van Dijk, J. H., Thuma, P. E., Nouwen, J. L., Baltussen, R. M. P. M., van de Wijgert, J. H. H. M., Sloot, P. M. A., & van de Vijver, D. A. M. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059549 · Cited by 44
Favoring “Peace of Mind”: A Qualitative Study of African Women's HIV Prevention Product Formulation Preferences from the MTN-020/ASPIRE Trial
van der Straten, A., Shapley‐Quinn, M. K., Reddy, K., Cheng, H., Etima, J., Woeber, K., Musara, P., Palanee-Phillips, T., Baeten, J. M., Montgomery, E., et al. (2017) · AIDS Patient Care and STDs · doi:10.1089/apc.2017.0075 · Cited by 44
Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
Strokappe, N. M., Hock, M., Rutten, L., McCoy, L. E., Back, J. W., Caillat, C., Haffke, M., Weiss, R. A., Weissenhorn, W., & Verrips, T. C. (2019) · Antibodies · doi:10.3390/antib8020038 · Cited by 44
Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial
Keller, M. J., Wood, L., Billingsley, J. M., Ray, L., Goymer, J., Sinclair, S., McGinn, A. P., Marzinke, M. A., Frank, B., Srinivasan, S., et al. (2019) · The Lancet HIV · doi:10.1016/s2352-3018(19)30145-6 · Cited by 44
COVID-19 in South Africa
Broadbent, A., Combrink, H., & Smart, B. T. H. (2020) · Global Epidemiology · doi:10.1016/j.gloepi.2020.100034 · Cited by 44
Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir
Clark, J. T., Johnson, T. J., Clark, M. R., Nebeker, J. S., Fabian, J., Tuitupou, A. L., Ponnapalli, S., Smith, E. M., Friend, D. R., & Kiser, P. F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.033 · Cited by 44
Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept
Abadi, L. F., Kumar, P., Paknikar, K. M., Gajbhiye, V., & Kulkarni, S. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01750-w · Cited by 43
Safer conception interventions for HIV-affected couples: implications for resource-constrained settings.
Chadwick, R. J., Mantell, J. E., Moodley, J., Harries, J., Zweigenthal, V., & Cooper, D. D. (2011) · Europe PMC (PubMed Central) · Cited by 43
Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment
Nelson, A. G., Zhang, X., Ganapathi, U., Székely, Z., Flexner, C. W., Owen, A., & Sinko, P. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.042 · Cited by 43
Topical microbicides for prevention of sexually transmitted infections
Obiero, J. A., Mwethera, P. G., & Wiysonge, C. S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007961.pub2 · Cited by 43
Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study
Dai, J. Y., Hendrix, C. W., Richardson, B. A., Kelly, C., Marzinke, M. A., Chirenje, Z. M., Marrazzo, J. M., & Brown, E. R. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv333 · Cited by 43
Global Action to reduce HIV stigma and discrimination
Stangl, A. L., Grossman, C. I., Sidibé, M., Goosby, E., Grossman, C. I., Stangl, A. L., Katz, I. T., Ryu, A. E., Onuegbu, A., Psaros, C., et al. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.3.18934 · Cited by 44
Genotypic and Functional Impact of HIV-1 Adaptation to Its Host Population during the North American Epidemic
Cotton, L. A., Kuang, X. T., Le, A. Q., Carlson, J. M., Chan, B., Chopera, D., Brumme, C. J., Markle, T. J., Martin, E., Shahid, A., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004295 · Cited by 43
Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial
Munseri, P., Kroidl, A., Nilsson, C., Joachim, A., Geldmacher, C., Mann, P., Moshiro, C. S., Aboud, S., Lyamuya, E., Maboko, L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119629 · Cited by 43
The Nonnucleoside Reverse Transcriptase Inhibitor MIV-150 in Carrageenan Gel Prevents Rectal Transmission of Simian/Human Immunodeficiency Virus Infection in Macaques
Singer, R., Derby, N. R., Rodriguez, A., Kizima, L., Kenney, J., Aravantinou, M., Chudolij, A., Gettie, A., Blanchard, J., Lifson, J. D., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02422-10 · Cited by 43
Pharmacokinetics of antiretrovirals in mucosal tissue
Cottrell, M. L., Srinivas, N., & Kashuba, A. D. M. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1027682 · Cited by 43
Colorectal microbicide design
Herrera, C., Cranage, M. P., McGowan, I., Anton, P. A., & Shattock, R. J. (2011) · AIDS · doi:10.1097/qad.0b013e32834b3629 · Cited by 43
Nuclear Receptor Signaling Inhibits HIV-1 Replication in Macrophages through Multipletrans-Repression Mechanisms
Hanley, T. M., & Viglianti, G. A. (2011) · Journal of Virology · doi:10.1128/jvi.00789-11 · Cited by 44
The male factor: Outcomes from a cluster randomized field experiment with a couples-based HIV prevention intervention in a South African township
Wechsberg, W. M., Zule, W. A., El‐Bassel, N., Doherty, I. A., Minnis, A. M., Novak, S. P., MYERS, B. J., & Carney, T. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.017 · Cited by 43
Metabolic Syndrome After HIV Acquisition in South African Women
Sobieszczyk, M. E., Werner, L., Mlisana, K. P., Naicker, N., Feinstein, A., Gray, C. M., Masson, L., Passmore, J.-A. S., Williamson, C. E., Karim, Q. A., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001123 · Cited by 43
Self-citation
Tenofovir Containing Thiolated Chitosan Core/Shell Nanofibers: In Vitro and in Vivo Evaluations
Meng, J., Agrahari, V., Ezoulin, M. J. M., Zhang, C., Purohit, S. S., Molteni, A., Dim, D. C., Oyler, N. A., & Youan, B.-B. C. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00739 · Cited by 43
Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use
Ustianowski, A., & Arends, J. E. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0070-1 · Cited by 43
Daily Short Message Service Surveys to Measure Sexual Behavior and Pre-exposure Prophylaxis Use Among Kenyan Men and Women
Curran, K., Mugo, N. R., Kurth, A., Ngure, K., Heffron, R., Donnell, D., Celum, C., & Baeten, J. M. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0510-4 · Cited by 42
Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission
El-Sadr, W. M., Coburn, B. J., & Blower, S. M. (2011) · AIDS · doi:10.1097/qad.0b013e32834c4c22 · Cited by 42
Combinations of Griffithsin with Other Carbohydrate-Binding Agents Demonstrate Superior Activity Against HIV Type 1, HIV Type 2, and Selected Carbohydrate-Binding Agent-Resistant HIV Type 1 Strains
Férir, G., Huskens, D., Palmer, K. E., Boudreaux, D. M., Swanson, M. D., Markovitz, D. M., Balzarini, J. M., & Schols, D. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0026 · Cited by 42
Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission
Barouch, D. H., Klasse, P. J., Dufour, J., Veazey, R. S., & Moore, J. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203183109 · Cited by 42
As Good As It Gets? The Problem of HIV Persistence despite Antiretroviral Drugs
Sigal, A., & Baltimore, D. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.07.005 · Cited by 42
In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine
Schader, S. M., Oliveira, M., Ibanescu, R.-I., Moisi, D. D., Colby-Germinario, S. P., & Wainberg, M. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05821-11 · Cited by 42
Lignosulfonic Acid Exhibits Broadly Anti-HIV-1 Activity – Potential as a Microbicide Candidate for the Prevention of HIV-1 Sexual Transmission
Qiu, M., Wang, Q., Chu, Y., Yuan, Z., Song, H., Chen, Z., & Wu, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035906 · Cited by 42
Overview of microbicides for the prevention of human immunodeficiency virus
Karim, S. S. A., & Baxter, C. (2012) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2012.01.010 · Cited by 42
Self-citation
Acceptability of Oral versus Rectal HIV Preexposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Peru
Peinado, J., Lama, J. R., Galea, J. T., Segura, P., Casapía, M., Ortiz, A., Montano, S. M., Kochel, T. J., & Sánchez, J. (2013) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/1545109712473650 · Cited by 42
Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection
Grooms-Williams, T. W., Vuong, H. R., Tyo, K. M., Malik, D. A., Sims, L. B., Whittington, C. P., Palmer, K. E., Matoba, N., & Steinbach-Rankins, J. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00956-16 · Cited by 42
Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges
Lee, C.-H. (2020) · Marine Drugs · doi:10.3390/md18090435 · Cited by 42
Real-Time Monitoring and Point-of-Care Testing: A Review of the Current Landscape of PrEP Adherence Monitoring
Hannaford, A., Arens, Y., & Koenig, H. C. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s248696 · Cited by 42
Prospects for a Globally Effective HIV-1 Vaccine
Excler, J., Robb, M. L., & Kim, J. H. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.09.004 · Cited by 41
Thermosensitive and Mucoadhesive Pluronic-Hydroxypropylmethylcellulose Hydrogel Containing the Mini-CD4 M48U1 Is a Promising Efficient Barrier against HIV Diffusion through Macaque Cervicovaginal Mucus
Bouchemal, K., AKA-ANY-GRAH, S., Dereuddre‐Bosquet, N., Martin, L., Moal, V. L.-L., Grand, R. L., Nicolas, V., Gibellini, D., Lembo, D., Poüs, C., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03503-14 · Cited by 41
Vaginal deployment and tenofovir delivery by microbicide gels
Gao, Y., Yuan, A., Chuchuen, O., Ham, A. S., Yang, K., & Katz, D. F. (2015) · Drug Delivery and Translational Research · doi:10.1007/s13346-015-0227-1 · Cited by 41
Pregnancy and Contraceptive Use Among Women Participating in the FEM-PrEP Trial
Callahan, R., Nanda, K., Kapiga, S., Malahleha, M., Mandala, J., Ogada, T., Damme, L. V., & Taylor, D. J. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000413 · Cited by 41
Self-citation
‘Test-and-treat’: the end of the HIV epidemic?
Cambiano, V., Rodger, A. J., & Phillips, A. N. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283422c8c · Cited by 41
Spray drying tenofovir loaded mucoadhesive and pH-sensitive microspheres intended for HIV prevention
Zhang, T., Zhang, C., Agrahari, V., Murowchick, J. B., Oyler, N. A., & Youan, B.-B. C. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.12.019 · Cited by 41
Hidden harms: Women's narratives of intimate partner violence in a microbicide trial, South Africa
Stadler, J., Delany‐Moretlwe, S., Palanee‐Phillips, T., & Rees, H. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.03.021 · Cited by 41
Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides
Rollenhagen, C., Lathrop, M. J., Macura, S. L., Doncel, G. F., & Asin, S. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.3 · Cited by 41
Antiviral Breadth and Combination Potential of Peptide Triazole HIV-1 Entry Inhibitors
McFadden, K., Fletcher, P. S., Rossi, F., Kantharaju, Umashankara, M., Pirrone, V., Rajagopal, S., Gopi, H. N., Krebs, F. C., Martín‐García, J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05555-11 · Cited by 41

Authors: Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., Gengiah, T. N., Maarschalk, S., Arulappan, N., Mlotshwa, M., Morris, L., Taylor, D., & on behalf of the CAPRISA 004 Trial Group
Affiliations: Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban 4013, South Africa.
Centre for the AIDS Programme of Research in South Africa (ZA)
National Institute for Communicable Diseases (ZA)
Family Health International 360 (US)
ORCID: Grobler, Anneke C.
Baxter, Cheryl
Mansoor, Leila E.
Kharsany, Ayesha B. M.
Sibeko, Sengeziwe
Mlisana, Koleka P.
Gengiah, Tanuja N.
Arulappan, Natasha
Morris, Lynn
Taylor, Douglas
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2010-09-03
Volume: 329
Issue: 5996
Pages: 1168-1174
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1193748
PMC: PMC3001187
OpenAlex: W2146634980
Cited by: 2,435
References: 33
Citations by year: 2026: 13 · 2025: 27 · 2024: 29 · 2023: 27 · 2022: 43 · 2021: 81 · 2020: 65 · 2019: 81 · 2018: 106 · 2017: 150 · 2016: 182 · 2015: 212 · 2014: 292 · 2013: 328 · 2012: 385
FWCI: 229.92
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Figshare (submittedVersion, cc-by)
ResearchSpace (University of KwaZulu-Natal) (submittedVersion)
Columbia Academic Commons (Columbia University)
Funders: National Institute of Allergy and Infectious Diseases (U01AI046749, U01AI068633, U19AI051794, U01AI068619, AI 51794)
Fogarty International Center (D43TW000231)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: tenofovir gel, HIV prevention, microbicides, vaginal gel, women, HIV incidence, antiretroviral drugs, nucleotide reverse transcriptase inhibitors, HIV seroconversion, tenofovir resistance, sexual behavior, condom use
MeSH terms: Tenofovir, Adenine, Administration, Intravaginal, Adolescent, Adult, Anti-Infective Agents, Local, Double-Blind Method, Female, Humans, Patient Compliance, Pregnancy, Pregnancy Outcome, Rural Population, Sexual Behavior, South Africa, Urban Population, Vaginal Creams, Foams, and Jellies, HIV-1, HIV Infections, Incidence, Anti-HIV Agents, Viral Load, Drug Resistance, Viral, Young Adult, Organophosphonates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks